Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Zuga Matt Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 4 HighCape Capital, L.P. (10% Owner) has filed a Form 4 on ELUTIA INC.
Txns: Bought 2,837,128 shares @ $0
Bought 4,255,693 warrants @ $1.4275, valued at $6.1M
06/12/2023 4 HighCape Capital, L.P. (10% Owner) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Granted 37,500 options to buy @ $2.37, valued at $88.9k
Granted 25,000 options to buy @ $2.37, valued at $59.3k
01/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2023 4 Zuga Matt (CFO and Chief Business Officer) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Exercised 50,000 options to buy @ $1.19, valued at $59.5k
12/07/2022 4 HighCape Capital, L.P. (10% Owner) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Bought 735,000 shares @ $4.75, valued at $3.5M
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/21/2022 4 Zuga Matt (CFO and Chief Business Officer) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 150,000 options to buy @ $5.19, valued at $778.5k
12/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/08/2021 4 Zuga Matt (CFO) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Converted 26,187 shares @ $0
Converted 15,659 preferred shares @ $0
Converted 10,528 preferred shares @ $0
06/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2020 4 HighCape Capital, L.P. (10% Owner) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Converted 4,062,451 shares @ $0
Paid exercise price by delivering 2,451 shares @ $5.4424, valued at $13.3k
Bought 441,176 shares @ $17, valued at $7.5M
Converted 31,133,977 convertible preferred @ $0
Exercised (in-or-at-the-money) 7,655 warrants @ $5.4424, valued at $41.7k
11/13/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy